Close filter

Content related to Health

Case Studies - Redefining Healthcare Leadership

The Egon Zehnder Health team are focused on areas of critical importance to its global health and well-being clients, including consumer centricity, data and technology and science, product innovation, global healthcare systems.

上下一心、共克新冠

企业领袖分享历次危机应对心得与对当下的启示

The Guardian - EU to Propose Enforcing 40% Quota for Women on Company Boards

The European commission is to push for a quota for women on company boards to address the slow progress to gender equality in the senior ranks of publicly listed businesses. Previous attempts by the EU’s executive to set a 40% goal for women in the top ranks of listed companies have been blocked by Germany, the Netherlands and Sweden overs fears that Brussels was overreaching into domestic affairs. Hungary and Poland have opposed the move on ideological grounds.

What We Heard – Convergence of Digital & Health

Egon Zehnder Istanbul recently hosted a presentation by Cozi Namer, Healthcare Industry Development Lead at Google, based in New York. As the subject of digital revolution continues to gain momentum in the performance-focused corporate world, healthcare industry is also in a state of constant transformation.

Quality: Biopharma’s New Secret Weapon

Health, Pharma and Leadership. Quality executives used to be the in-house police; internal affairs officers investigating production errors and mishaps and reporting them up the chain of command.

New Strategic Information and Technology Roles in Life Sciences Companies

Fundamental changes in the marketplace for medicines, as well as the rapid and continuing evolution of technology are bringing new challenges and opportunities for life sciences companies and their contribution to healthcare systems.

The Boston Globe – Are Some Directors “Overboarding”?

With Sarbanes-Oxley increasing the responsibilities shouldered by today’s directors, do some individuals have a seat on too many US boards, asks The Boston Globe?

The Slow One Loses This Race

Healthcare has been in a state of steady, sometimes grudging, transformation for years. What’s different today is the dramatically accelerated pace of change that has been brought on by a combination of regulatory pressures, high costs, consumer empowerment, and revolutionary technological and medical innovation.

Life Sciences Survey 2010 – Managerial Competencies in the Generics Sector

The generics industry has entered a phase of radical transformation. Rapid globalization, continuing consolidation, and increasing business complexity have turned formerly regional players into global operations.

Changing language
Close icon

You are switching to an alternate language version of the Egon Zehnder website. The page you are currently on does not have a translated version. If you continue, you will be taken to the alternate language home page.

Continue to the website

Back to top